Skip to content

Author

D. Koschel

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Brief report: Clinical and Functional Characterization of Rare Germline and Somatic EGFR Variants in Three Patients with Non-Small Cell Lung Cancer.

Findings highlight the clinical relevance of germline EGFR variants in NSCLC and support the value of in-silico and in-vitro analyses for variant interpretation and response prediction.

R. Prielipp, C. Albers-Leischner, Yana Sharapova et al. · 0 citations
Open access Oct 2026

Increased number of chemotherapy cycles during radiochemotherapy improves overall survival without increasing toxicity in locally advanced non-small cell lung cancer patients.

PURPOSE Radiochemotherapy (RCHT) followed by immunotherapy is the standard of care for unresectable, locally advanced non-small cell lung cancer (LA-NSCLC) patients. However, the impact of chemotherapy cycles and consolidation durvalumab on overall survival and toxicity remains uncertain in a real-life cohort. METHOD...

A. Simbirova, Steffen Loeck, S. Appold et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.